ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

Panel Says NIH Must Devise Means For Early Release Of Trials Data

January 25, 1991

FDA Approves Lapatinib For Advanced Breast Cancer

March 30, 2007

Studies Seek to Identify High-Risk Groups to Justify Mammography Screening at 40

May 4, 2012

Multivitamin Use Doesn’t Impact Outcomes, Study Finds

September 24, 2010

In Brief: Angel Bradley, NCAB Member, Dies; Three State Colorectal Cancer Screening Effort Big Success

July 5, 1985

In Brief: Gerald Dodd, Walter Lawrence Head ACS; Reauthorization Bills Expected Early ‘91

November 16, 1990